Cleared Traditional

K161519 - NeuroStar TMS Therapy System

K161519 is an FDA 510(k) clearance for NeuroStar TMS Therapy System, manufactured by Neuronetics, Inc.. The device is a Class 2 Neurology device with product code OBP cleared through the Traditional 510(k) pathway after a 101-day FDA review.

K161519 · Neuronetics, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
101d
Days
Class 2
Risk

K161519 is an FDA 510(k) clearance for the NeuroStar TMS Therapy System. Classified as Transcranial Magnetic Stimulator (product code OBP), Class II - Special Controls.

Submitted by Neuronetics, Inc. (Malvern, US). The FDA issued a Cleared decision on September 11, 2016 after a review of 101 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5805 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neuronetics, Inc. devices

FDA 510(k) Submission Details - K161519

510(k) Number K161519 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2016
Decision Date September 11, 2016
Days to Decision 101 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 149d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OBP Device Classification - Class 2, Special Controls

Product Code OBP Transcranial Magnetic Stimulator
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5805
Definition A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OBP Transcranial Magnetic Stimulator

All 68
Devices cleared under the same product code (OBP) and FDA review panel - the closest regulatory comparables to K161519.
MagVita TMS Therapy - w/MagPro R20
K170114 · Tonica Elektronik A/S · May 2017
Rapid2 Therapy System
K162935 · Magstim Company, Ltd. · Mar 2017
Neurosoft TMS
K160309 · Teleemg, LLC · Dec 2016
NeuroStar TMS Therapy System
K160703 · Neuronetics, Inc. · Jun 2016
MagVita TMS Therapy System
K150641 · Tonica Elektronik A/S · Jul 2015
Rapid Therapy System
K143531 · Magstim Company Limited · May 2015